AUTHOR & ACADEMIC PRINCIPAL

Nguyễn Đình Quang

Independent medical researcher | Founder, Vien Gut | System architect of the HOW — DATA-to-operate / operational layer

HOW AND DATA-TO-OPERATE DESIGN CONTRIBUTORS — VIEN GUT

Nguyễn Đình Quang Huy  HOW — DATA-to-operate design contributor | Operational management, transfer coordination — Vien Gut Model

Huỳnh Phước Đại, Nguyễn Sơn  Patient-language editorial | Communications data governance, deployment and transfer support — Vien Gut Model

ACADEMIC SUPPORT & WHAT (GUIDELINE) BENCHMARKING — INTERNATIONAL EXPERT GROUP

Thomas Bardin, Pascal Richette Co-authors of EULAR Recommendations — together with experts in cardiology, nephrology, hepatology, diabetology, diagnostic imaging, and biostatistics at Université Paris Cité, France, and Sorbonne University. Transfer of WHAT from treatment guidelines for gout and comorbidities; international benchmarking of WHAT; HOW design support — Vien Gut Model.

DATA GOVERNANCE TEAM — VIEN GUT

Trương Ánh Dương, Huỳnh Hồng Đức  Data governance, transfer support — Vien Gut Model

TREATING PHYSICIAN GROUP + MULTIDISCIPLINARY TEAM — VIEN GUT POLYCLINIC

Clinical HOW deployment: risk stratification, opportunity window, longitudinal monitoring, risk management, polypharmacy governance, referral safety valve activation — Vien Gut Model.

RESEARCH SITE

Franco-Vietnamese Center for Research on Gout and Chronic Diseases

Vien Gut Polyclinic, 13A Hồng Hạ Street, Tân Sơn Hòa Ward, Ho Chi Minh City, Vietnam

PLACE OF THIS DOCUMENT IN THE VIEN GUT DOSSIER

Document A.5 is not a long-form explanatory document on foundational academic concepts like A.1-A.3, nor is it a document that fully defines each term like A.4. A.5 is a condensed standardization reference designed to unify language across the entire dossier. If A.4 is the “full operational dictionary,” then A.5 is the “rapid standardization table” for writers, readers, reviewers, and academic dialogue partners. It standardizes six content groups: the four verification targets, the HOW terminology system, biomarkers and action thresholds, imaging modalities, international guideline terms cited across the dossier, and the standardized abbreviation-symbol system.

A.5 belongs to Tier 1 – Basic Architecture. It serves all of Part A, Part B, Part C, and Part D. Its role is not to replace A.4, but to provide a unified reference so that every document in the dossier uses the same names, symbols, thresholds, and interpretive framework.

READER GUIDE TO A.5

  • To understand the overall architectural statement of the dossier, read A.0.
  • To understand the EBM WHAT – HOW – DATA-to-operate framework, read A.1.
  • To understand the definitions of the three foundational layers, read A.2.
  • To understand the international evidence for the global HOW gap, read A.3.
  • To understand the full definitions of all operational terms, read A.4.
  • To see how these terms, thresholds, and tools are implemented in the outpatient model, read B.1-B.5.
  • To see how they are applied to each disease axis, read C.1-C.n.

ABSTRACT

A.5 is the official standardization table of the Vien Gut Model academic dossier. Its purpose is to ensure that all documents in the dossier use the same language, the same notation system, the same naming conventions for the verification targets, the same names for biomarkers and action thresholds, the same imaging toolkit, and the same system of abbreviations. A.5 does not replace A.4 in conceptual depth; rather, it condenses and standardizes what A.4 has already defined in order to support rapid lookup and consistent use throughout drafting, academic dialogue, and validation.

References

The references for A.5 are organized into six thematic groups corresponding to the six terminology groups above. The bracketed numbering is used consistently throughout the full 36-document dossier. Group 1 covers gout guidelines and verification targets; Group 2 covers integrated care and multimorbidity; Group 3 covers laboratory guidelines and biological thresholds; Group 4 covers imaging modalities and international standards; Group 5 covers implementation science and guideline frameworks; Group 6 covers operations and governance. The complete reference list for A.5 is retained exactly as in the original version.

  • [1] FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744–760.
  • [2] Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42.
  • [3] Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Ann Rheum Dis. 2006;65(10):1312–1324.
  • [4] Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout Classification Criteria: an ACR/EULAR collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–1798.
  • [5] Pascual E, Sivera F, Andres M. Synovial fluid analysis for crystals. Curr Opin Rheumatol. 2011;23(2):161–169.
  • [6] World Health Organization. Framework on Integrated, People-centred Health Services. Geneva: WHO; 2016.
  • [7] Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care. Lancet. 2012;380(9836):37–43.
  • [8] Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20(6):64–78.
  • [9] World Health Organization. Integrated Care for Older People (ICOPE). Geneva: WHO; 2019.
  • [10] Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–2874.
  • [11] Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341.
  • [12] Pham HH, Schrag D, O’Malley AS, Wu B, Bach PB. Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007;356(11):1130–1139.
  • [13] World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013–2030. Geneva: WHO; 2023.
  • [14] KDIGO CKD Work Group. KDIGO 2024 Clinical Practice Guideline for CKD. Kidney Int. 2024;105(4S):S117–S314.
  • [15] McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726.
  • [16] European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines for decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
  • [17] Caraceni P, Tonon M, Vizzutti F, et al. Definition and diagnosis of refractory ascites in cirrhosis. Dig Liver Dis. 2019;51(5):611–615.
  • [18] Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–1749.
  • [19] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol. 2018;72(18):2231–2264.
  • [20] Gutierrez M, Schmidt WA, Thiele RG, et al. International Consensus for ultrasound lesions in gout. Rheumatology. 2015;54(10):1797–1805.
  • [21] Bongartz T, Glazebrook KN, Kavros SJ, et al. Dual-energy CT for the diagnosis of gout. Ann Rheum Dis. 2015;74(6):1072–1077.
  • [22] Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in NAFLD: a comparison of SSI, FibroScan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817–1827.
  • [23] Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults. J Am Soc Echocardiogr. 2015;28(1):1–39.
  • [24] Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines on Clinical Use of Liver Ultrasound Elastography. Ultraschall Med. 2017;38(4):377–394.
  • [25] Eccles MP, Mittman BS. Welcome to Implementation Science. Implement Sci. 2006;1:1.
  • [26] Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change. Lancet. 2003;362(9391):1225–1230.
  • [27] Graham ID, Logan J, Harrison MB, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26(1):13–24.
  • [28] World Health Organization. Knowledge translation for public health. Geneva: WHO; 2004.
  • [29] Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence. BMJ. 2008;336(7650):924–926.
  • [30] Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–72.
  • [31] Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ. 2008;337:a1714.
  • [32] Coleman EA. Falling through the cracks: challenges for improving transitional care for persons with complex care needs. J Am Geriatr Soc. 2003;51(4):549–555.
  • [33] Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–1539.
  • [34] Deane KD, O’Donnell CI, Hueber W, et al. The number of elevated cytokines in preclinical seropositive RA predicts time to diagnosis. Arthritis Rheum. 2010;62(11):3161–3172.
  • [35] Institute of Medicine (IOM). Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington DC: National Academies Press; 2013.

Related Documents

Document A.0: Architectural Declaration
Four Verification Targets on Target Organs as the Central Reference Framework of the Publication Set
Vien Gut Model — Academic Publication Set: 01-SC: 2026 Mar

Document A.1: EBM Reference Framework: What - How - Data to operate
From Gap to Operable Structure
Vien Gut Model — Academic Publication Set: 01-SC: 2026 Mar

Document A.2: Foundational Concept set: What - How - Data to operate
Identification, Definition, and Separation of the Three Architectural Layers of the Vien Gut Model. Reading foundation for the entire publication set
Vien Gut Model — Academic Publication Set: 01-SC: 2026 Mar

Document A.3: The global HOW Gap
Why Complex Chronic Multimorbidity Is Not Served by Existing Single-Disease Guidelines
Vien Gut Model — Academic Publication Set: 01-SC: 2026 Mar

Document A.4: Operational Concept Set
Identification and Definition of All HOW Terminology Unified Reference for the Entire Publication Set
Vien Gut Model — Academic Publication Set: 01-SC: 2026 Mar

Document A.5: Standardized Glossary
6 thematic groups · 60 HOW terms · 28 biomarkers & thresholds 18 imaging modalities · 77+ abbreviations
Vien Gut Model — Academic Publication Set: 01-SC: 2026 Mar

View PDF

Download full text

View the Presentation

Share

FULL TEXT LINK

Download full text

ACTIONS

View PDF

View the present

Share

PAGE NAVIGATION

Title | Authors
Reader Guide
Abstract
Related Documents

Electronic information portal providing specialized services (medicine and science & technology) of Vien Gut Company Limited. Compliant with Article 24, Clause 2 of Decree No. 147/2024/ND-CP, GDPR, and CCPA/CPRA.

COMPLIANT WITH DECREE NO. 147/2024/ND-CP (VIETNAM), GDPR (EU), AND CCPA/CPRA (U.S.).